NeoHealth Revenue and Competitors

Hasbrouck Heights, NJ USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • NeoHealth's estimated annual revenue is currently $5M per year.(i)
  • NeoHealth's estimated revenue per employee is $201,000

Employee Data

  • NeoHealth has 25 Employees.(i)
  • NeoHealth grew their employee count by 0% last year.

NeoHealth's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M25-11%N/AN/A
#2
$35.8M1788%N/AN/A
#3
$5.4M27-25%N/AN/A
#4
$4180M145161%$550MN/A
#5
$12.5M6215%N/AN/A
#6
$6.7M119-37%$199.6MN/A
#7
$9.4M477%N/AN/A
#8
$10.3M516%N/AN/A
#9
$106.3M52916%N/AN/A
#10
$15.5M7720%N/AN/A
Add Company

What Is NeoHealth?

NeoHealth, Inc. provides comprehensive healthcare marketing and communications services to the pharmaceutical and biotech industries. We are a science driven company built upon a deep understanding of the principles that drive effective communications. We understand how health care practitioners learn, evaluate data, and ultimately adopt new practices. We believe in the power of interaction and persuasive dialogue when fueled by the latest innovations in science and medicine and incorporate this philosophy into the development of leading edge medical education, promotional peer-to-peer, and speaker bureau services to guide your clinicians’ learning experiences. As a privately owned, mid-sized company, we are able to embrace a customer-centric philosophy, believe in fully customized deliverables to meet each client’s unique needs, and offer concierge level service and account management to our customers and their stakeholders. Tell us how we might assist with your needs by contacting us info@neohealth.com

keywords:N/A

N/A

Total Funding

25

Number of Employees

$5M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.8M28-3%N/A
#2
$4.9M29-19%N/A
#3
$6.7M313%N/A
#4
$3.7M317%N/A
#5
$8.6M40-2%N/A